Abstract
This report analyzes the worldwide markets for Drug-Eluting Stents in Millions
of US$. The report provides separate comprehensive analytics for the US,
Japan, Europe, and Rest of World. Annual forecasts are provided for each
region for the period of 2003 through 2015. The report profiles 39 companies
including many key and niche players worldwide such as Abbott Vascular,
Angiotech Pharmaceuticals, Inc., AngioDynamics®, Inc., Boston Scientific,
Inc., Boston Scientific Cardiac Rhythm Management, Biocompatibles
International PLC, Biosensors International Pte Ltd., Cordis Corporation,
Implant Sciences Corporation, Medtronic, Inc., MIV Therapeutics, Inc., and
SurModics, Inc. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
View Cart
